# Retraction: Hong Liu, Shi‐Ying Ren, Yan Qu, Cui Liu, Yi Zhang, Xiang Qing Li, Hong Ma. MiR‐194‐5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk. The Kaohsiung Journal of Medical Sciences, Volume 36, Issue 4 Apr 2020. Pages 265–273. https://doi.org/10.1002/kjm2.12180

PMC · DOI: 10.1002/kjm2.12727 · The Kaohsiung Journal of Medical Sciences · 2023-06-28

## TL;DR

This paper was retracted because it was submitted and published without the consent of several co-authors.

## Contribution

The paper has no valid contribution as it was retracted due to unauthorized submission.

## Key findings

- The article was published without consent from several co-authors.
- The retraction was agreed upon by some authors and the journal's Editor-in-Chief.

## Abstract

The above article, published online on 31 December 2019, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between Hong Ma, Cui Liu and Yan Qu, the journal Editor‐in‐Chief, Wan‐Long Chuang, and John Wiley and Sons Ltd. The retraction has been agreed because the article was submitted and approved for publication by Hong Liu without consent from the named co‐authors Shi‐Ying Ren, Yan Qu, Cui Liu, Yi Zhang, Xiang Qing Li, and Hong Ma. Other authors were not available for a final confirmation of the retraction.

## Full-text entities

- **Genes:** CRK (CRK proto-oncogene, adaptor protein) [NCBI Gene 1398] {aka CRKII, p38}
- **Diseases:** metastasis (MESH:D009362), nephroblastoma (MESH:D009396)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11895608/full.md

---
Source: https://tomesphere.com/paper/PMC11895608